Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
213,199,938
-
Share change
-
+136,275
-
Total reported value
-
$102,775,746,647
-
Put/Call ratio
-
110%
-
Price per share
-
$482.58
-
Number of holders
-
1,410
-
Value change
-
-$36,977,206
-
Number of buys
-
628
-
Number of sells
-
594
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2022
As of 30 Jun 2022,
Elevance Health, Inc. - Common Stock (ELV) was held by
1,410 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
213,199,938 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Capital International Investors, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, and Sanders Capital, LLC.
This page lists
1,423
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.